Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.

Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.
复制标题

DOI:
10.1016/j.ccell.2018.01.012
复制
发表时间:
2018-03-12
期刊:
影响因子:
50.3
通讯作者:
Maeda T
Maeda T
中科院分区:
医学1区
文献类型:
--
作者:
Yamauchi T;Masuda T;Canver MC;Seiler M;Semba Y;Shboul M;Al-Raqad M;Maeda M;Schoonenberg VAC;Cole MA;Macias-Trevino C;Ishikawa Y;Yao Q;Nakano M;Arai F;Orkin SH;Reversade B;Buonamici S;Pinello L;Akashi K;Bauer DE;Maeda T

文献摘要

参考文献

被引文献

相似文献

为了确定急性髓性白血病(AML)治疗的新靶点,我们使用AML细胞系进行了全基因组CRISPR-Cas9筛选,然后进行了体内第二次筛选。在这里,我们表明,mRNA脱帽酶清除剂(DCPS)基因是AML细胞生存所必需的。如质谱所示,DCPS酶与前mRNA代谢途径的组分相互作用,包括剪接体。RG 3039是一种最初开发用于治疗脊髓性肌萎缩症的DCPS抑制剂,通过诱导前体mRNA错误剪接表现出抗白血病活性。携带生殖系双等位基因DCPS功能丧失突变的人不表现出异常的血液学表型,表明DCPS对人类造血作用不利。我们的研究结果揭示了前mRNA代谢途径,并确定DCPS作为AML治疗的靶点。Yamauchi等人对p53 WT AML进行了体外和体内CRISPR-Cas9遗传筛选,以鉴定潜在的治疗靶点。他们发现AML依赖于DCPS脱帽酶,DCPS抑制剂在肿瘤模型中显示出抗白血病活性,而不影响正常的造血。
To identify novel targets for acute myeloid leukemia (AML) therapy, we performed genome-wide CRISPR-Cas9 screening using AML cell lines, followed by a second screen in vivo. Here, we show that the mRNA decapping enzyme scavenger (DCPS) gene is essential for AML cell survival. The DCPS enzyme interacted with components of pre-mRNA metabolic pathways, including spliceosomes, as revealed by mass spectrometry. RG3039, a DCPS inhibitor originally developed to treat spinal muscular atrophy, exhibited anti-leukemic activity via inducing pre-mRNA mis-splicing. Humans harboring germline bi-allelic DCPS loss-of-function mutations do not exhibit aberrant hematologic phenotypes, indicating that DCPS is dispensable for human hematopoiesis. Our findings shed light on a pre-mRNA metabolic pathway and identify DCPS as a target for AML therapy. Yamauchi et al. perform in vitro and in vivo CRISPR-Cas9 genetic screening of p53 WT AML to identify potential therapeutic targets. They find that AML relies on the DCPS decapping enzyme, and a DCPS inhibitor shows anti-leukemia activity in tumor models without impacting normal hematopoiesis.
DOI: 10.1038/nbt.3437
发表时间: 2016-02
影响因子: 46.9
作者:
Doench JG;Fusi N;Sullender M;Hegde M;Vaimberg EW;Donovan KF;Smith I;Tothova Z;Wilen C;Orchard R;Virgin HW;Listgarten J;Root DE
通讯作者: Root DE
Biopython:用于计算分子生物学和生物信息学的免费 Python 工具。
DOI: 10.1093/bioinformatics/btp163
发表时间: 2009-06-01
期刊: Bioinformatics (Oxford, England)
影响因子: --
作者:
Cock PJ;Antao T;Chang JT;Chapman BA;Cox CJ;Dalke A;Friedberg I;Hamelryck T;Kauff F;Wilczynski B;de Hoon MJ
通讯作者: de Hoon MJ
DOI: 10.1016/s1097-2765(04)00180-7
发表时间: 2004-04-09
期刊: MOLECULAR CELL
影响因子: 16
作者:
Gu, MG;Fabrega, C;Lima, CD
通讯作者: Lima, CD
DOI: 10.1126/science.1225829
发表时间: 2012-08-17
期刊: SCIENCE
影响因子: 56.9
作者:
Jinek, Martin;Chylinski, Krzysztof;Charpentier, Emmanuelle
通讯作者: Charpentier, Emmanuelle
DOI: 10.1038/nbt.2507
发表时间: 2013-03-01
影响因子: 46.9
作者:
Cho, Seung Woo;Kim, Sojung;Kim, Jin-Soo
通讯作者: Kim, Jin-Soo